March 22, 2023 — Nuance Communications, Inc., a Microsoft company, has announced DAX Express, its next milestone in its portfolio of solutions combining OpenAI’s GPT-4 with proven workflow-integrated technology to define the future of intelligence-infused healthcare experiences.

The American Society of Breast Surgeons 24th Annual Meeting

March 21, 2023 — Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical services, is pleased to announce that it has executed a Clinical Study/Research Agreement with Ochsner Clinic Foundation and Dr.

March 21, 2023 — Boston Imaging, a subsidiary of Samsung Electronics, Co. Ltd, appoints Eric Sumner as the new Digital Radiography (DR) business leader for the United States. This move signals the next chapter in Samsung’s medical imaging growth in the U.S. and expand access to innovative DR technology. 

March 20, 2023 — A study by Emory Healthcare reports that Konica Minolta Healthcare’s Dynamic Digital Radiography (DDR), an enhanced version of a standard X-ray system that captures motion, provides more quantitative information on shoulder motion and a g

March 20, 2023 — RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced the completion of enrollment in the Phase 1b portion of the ACTION-1 Phase 1b/3 trial of RYZ101 in patients with SSTR+ gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who have progressed on Lutetium-177 labelled somatostatin analogue therapy.

March 20, 2023 — Researchers from UNSW Sydney have developed an algorithm which produces high-resolution modeled images from lower-resolution micro X-ray computerized tomography (CT).

March 17, 2023 — A new paper published in the Journal of Medical Internet Research describes how generative models such as DALL-E 2, a novel deep learning model for text-to-image generation, could represent a promising future tool for image generation, augmentation, and manipulation in health care. Do generative models have sufficient medical domain knowledge to provide accurate and useful results?

March 16, 2023 — A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to treat metastatic prostate cancer, has led to shortages resulting in a delay of 3 months or longer for new patients, which is having a profound negative impact on patient care.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now